Biotherapy : (Record no. 12517)

MARC details
000 -LEADER
fixed length control field 02141cam a22002894a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240202065142.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 000814s2001 maua b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0763714283
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0763719196
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780763719197
040 ## - CATALOGING SOURCE
Original cataloging agency BUL
Transcribing agency BUL
Modifying agency BUL
Language of cataloging eng
Description conventions rda
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number WB 365 B616 2001
245 00 - TITLE STATEMENT
Title Biotherapy :
Remainder of title a comprehensive overview /
Statement of responsibility, etc. edited by Paula Trahan Rieger.
250 ## - EDITION STATEMENT
Edition statement 2nd edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Boston, Ma :
Name of publisher, distributor, etc. Jones and Bartlett,
Date of publication, distribution, etc. c2001.
300 ## - PHYSICAL DESCRIPTION
Extent xxiv, 807 p. :
Other physical details ill. ;
Dimensions 24 cm.
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE
Title Jones and Bartlett series in oncology
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents<br/><br/>Part 1. Biotherapy: principles and foundations. <br/>Chapter 1. Biotherapy: an overview <br/>Chapter 2. The immune system <br/>Chapter 3. Normal cell biology and the biology of cancer <br/>Chapter 4. Optimizing the dose and schedule of biological agents. <br/><br/>Part 2. Major categories of biological agents. <br/>Chapter 5. The interferons <br/>Chapter 6. The interleukins <br/>Chapter 7. Hematopoietic growth factors <br/>Chapter 8. Monoclonal antibodies: overview and use in hematologic malignancies <br/>Chapter 9. Monoclonal antibodies: applications in solid tumors and other diseases <br/>Chapter 10. Cancer vaccines <br/>Chapter 11. Tumor necrosis factor <br/>Chapter 12. The retinoids <br/>Chapter 13. Gene therapy. <br/><br/>Part 3. Nursing management and future perspectives. <br/>Chapter 14. Patient management <br/>Chapter 15. Upside down: life with lymphoma <br/>Chapter 16. Flu-like syndrome <br/>Chapter 17. Fatigue<br/>Chapter 18. Anorexia as a side effect of biotherapy <br/>Chapter 19. Mental status changes associated with biotherapy <br/>Chapter 20. Patient education <br/>Chapter 21. The role of disease management in reimbursement for biotherapy <br/>Chapter 22. The future of cancer therapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biological response modifiers
General subdivision Therapeutic use.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Immunotherapy.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rieger, Paula Trahan.
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c orignew
d 1
e ocip
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book Open Access
Edition 2nd edition
Classification part WB 365
Item part 1
Call number prefix B616 2001
Call number suffix WB 365 B616 2001
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 04/20/2022 Donation 03593   WB 365 B616 2001 MBAL22041056 04/20/2022 1 04/20/2022 Book Open Access